JCB Laboratories
Fagron Sterile Services US is a DEA- and FDA-registered 503B pharmaceutical outsourcing facility that compounds sterile medications across five service categories for US hospitals, medical centers, and specialty practices, operating 268K+ ft² of cGMP capacity across three US facilities.
- Company typePrivate
- Founded2003
- HeadquartersWichita, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What JCB Laboratories does
Fagron Sterile Services US (FSS), operating under or alongside the JCB Laboratories identity in the available source data, is a DEA- and FDA-registered 503B pharmaceutical outsourcing facility that compounds and repackages sterile medications for US hospitals, medical centers, and specialty clinical practices. The company produces pre-filled syringes, IV bags, and ready-to-administer sterile solutions across five service categories: Critical Care (e.g., phenylephrine IV bags), Labor & Delivery (oxytocin, epidural solutions), Ophthalmics (combo eye drops, mitomycin, moxifloxacin), Pain Management (bupivacaine, ropivacaine, fentanyl, hydromorphone), and Specialty Presentations (sterile L.E.T. Gel, mito-bladder syringes for USP <800> compliance, and repackaged bevacizumab/Avastin® in Daikyo Crystal Zenith® syringes).
Production runs on 268K+ ft² of cGMP-compliant capacity across three US facilities in Wichita, Kansas (headquarters), Boston, Massachusetts, and Austin, Texas, using semi-automated operations including Groninger automation for sterile filling. All batches are tested for sterility, particulate matter, and potency. Advanced TALLman lettering on labels aligns with ISMP, FDA, USP, and ASTM color standards to mitigate medication errors. The company is part of the global Fagron organization, which operates 4,000+ employees, 70+ facilities, and serves 30+ countries, leveraging 3,000+ suppliers for supply chain resiliency.
FSS sells direct to enterprise healthcare buyers via a field sales motion with a structured 4-step onboarding process (Explore, Consult, Set up account, Place order), quote-based pricing, free consultations, and an Instant Ship Program for in-stock medications. Customers include a National Group Purchasing Organization, state pharmacy regulators, and named major medical centers, with the company reporting it is trusted by thousands of clinicians supporting millions of patient procedures annually.
JCB Laboratories firmographics
Firmographics- Name
- JCB Laboratories
- Website
- https://jcblabs.com
- Company type
- Private
- Founded year
- 2003
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Fagron Sterile Services US is a DEA- and FDA-registered 503B pharmaceutical outsourcing facility that compounds sterile medications across five service categories for US hospitals, medical centers, and specialty practices, operating 268K+ ft² of cGMP capacity across three US facilities.
- Ownership category
- akta.pro rank
JCB Laboratories industry classification
Industry- Product category
- Sterile Pharmaceutical Compounding (503B Outsourcing)
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254), Pharmaceutical and Medicine Manufacturing (32541)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Generic Finished Dosage Form (FDF) Manufacturing (HLAIABAH)
Keywords
Where JCB Laboratories is headquartered
LocationHeadquarters
- HQ city
- Wichita
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
JCB Laboratories business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Supply Chain, Infrastructure, Technology or R&D, Marketing or Sales
Revenue model
- Pharmaceutical Compounding Products: Sale of high-quality sterile medication preparations including Critical Care, Labor & Delivery, Ophthalmics, Pain Management, and Specialty Presentations. Products include pre-filled syringes, IV bags, and ready-to-administer solutions.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Contact sales for custom pricing |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels4 records
JCB Laboratories product offering
Product offeringCore offering
Fagron Sterile Services US is a DEA- and FDA-registered 503B pharmaceutical outsourcing facility that compounds and distributes sterile medication preparations to hospitals, medical centers, and specialty practices. Its portfolio spans pre-filled syringes, IV bags, and unit-of-use presentations across Critical Care, Labor & Delivery, Ophthalmics, Pain Management, and Specialty Presentations, all produced under cGMP-compliant operations inspected against 21 CFR 210 and 211 standards.
Product overview
Fagron Sterile Services US is a DEA and FDA-registered 503B pharmaceutical outsourcing company offering a vertically integrated portfolio of sterile compounding services. The company operates across five service categories: Critical Care (pre-filled IV solutions like phenylephrine), Labor & Delivery (oxytocin, epidural solutions), Ophthalmics (combo eye drops, mitomycin, moxifloxacin), Pain Management (bupivacaine, ropivacaine, fentanyl), and Specialty Presentations (L.E.T. Gel, mito-bladder syringes, repackaged Avastin®). The Instant Ship Program provides in-stock medications ready for immediate shipment. All products are manufactured through 268K+ ft² of cGMP-compliant capacity across three facilities in Wichita, KS, Boston, MA, and Austin, TX.
Differentiator
Problem solved
Functional benefit
Products and services
- Critical Care Sterile Preparations Pre-filled, ready-to-administer sterile solutions for surgical settings including phenylephrine IV bags, with advanced labeling featuring TALLman lettering to mitigate medication errors; targeted at hospitals and critical care departments.
- Labor & Delivery Sterile Preparations High-quality sterile medications including oxytocin and epidural solutions supporting maternal and neonatal care in hospitals and birth centers.
- Ophthalmics Sterile Preparations Comprehensive ophthalmic products including combination eye drops, mitomycin, and moxifloxacin for surgical and therapeutic applications in eye care practices and ophthalmic surgery centers.
- Pain Management Sterile Preparations Preservative-free corticosteroids and anesthetics including bupivacaine, ropivacaine, fentanyl, and hydromorphone in unit-of-use presentations for pain management protocols and USP 800 compliance.
- Specialty Presentations Innovative offerings including L.E.T. Gel (first and only sterile formulation), mito-bladder syringes for USP 800 compliance, and repackaged Avastin in Crystal Zenith syringes for specialty practices.
- Phenylephrine HCl 25mg/250mL IV Bag Featured critical care product prepared through state-of-the-art semi-automated cGMP-compliant operations with advanced TALLman lettering labeling aligned with ISMP, FDA, USP, and ASTM standards.
- Bevacizumab (Avastin®) Injection Syringe Repackaged bevacizumab (Avastin®) in Daikyo Crystal Zenith® syringe produced with Groninger automation through cGMP-compliant operations for ophthalmic and specialty practices.
- Instant Ship Program In-stock, ready to ship medications for immediate delivery when needed, supporting clinicians with urgent medication requirements.
- 503B Outsourcing Services DEA and FDA-registered pharmaceutical outsourcing including sterile medication preparation, repackaging, and manufacturing under cGMP-compliant 21 CFR 210 and 211 standards for healthcare facilities.
Quantifiable outcome
- Millions of patient procedures supported annually
- +2 more outcomes
Companies that use JCB Laboratories
Customer profileNamed customers3 records
Segments5 records
Ideal customer profiles5 records
JCB Laboratories technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
JCB Laboratories partnerships and signals
Strategic signalScale indicators8 records
Recent moves5 records
Expansion highlights5 records
JCB Laboratories competitors and assessment
Company assessmentDirect peers
- Leiters: Leiters is a 503B registered outsourcing facility specializing in sterile injectable compounding, including ready-to-administer preparations, directly comparable to FSS's core offerings in Critical Care and ophthalmics.
- QuVa Pharma: QuVa Pharma is a leading 503B outsourcing facility producing sterile injectable preparations for hospital systems, directly competing with FSS across Critical Care, Pain Management, and ophthalmic categories.
- Empower Pharmacy: Empower Pharmacy operates 503A and 503B compounding operations serving hospitals and clinics with sterile preparations, overlapping with FSS in sterile injectable and ophthalmic categories.
- AnazaoHealth: AnazaoHealth is a 503B outsourcing facility producing sterile injectable and compounded preparations, with comparable focus on hospital and specialty practice customers.
- Pharmaceutics International (Pii): Pii is a CDMO with 503B outsourcing capabilities producing sterile injectable and pre-filled syringe products, overlapping with FSS in hospital-facing sterile compounding services.
- US Pharma Lab: US Pharma Lab operates an FDA-inspected 503B outsourcing facility producing sterile injectable preparations for hospitals, directly competing with FSS in ready-to-administer solutions and pre-filled syringes.
Broad incumbents
- Patheon (Thermo Fisher Scientific): Patheon, part of Thermo Fisher's pharma services division, offers large-scale sterile injectable manufacturing and fill-finish services, representing a broader CDMO incumbent competing in the same end markets as FSS.
- Hikma Pharmaceuticals: Hikma is a global sterile injectable manufacturer with significant US hospital channel presence. Its generic sterile injectable portfolio overlaps with FSS's Critical Care and Pain Management categories as a broader industry incumbent.
- Catalent: Catalent is a large global CDMO offering sterile injectable fill-finish and pre-filled syringe manufacturing services. While much broader in scope, its sterile injectable capabilities overlap meaningfully with FSS's biologic repackaging and pre-filled syringe offerings.
- Sagent Pharmaceuticals: Sagent Pharmaceuticals manufactures and distributes sterile injectable products with a focus on hospital and acute care settings, providing broader-incumbent competition in injectable categories where FSS operates.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
JCB Laboratories social profiles
Digital presenceJCB Laboratories compliance and trust
Trust signalCompliance3 records
JCB Laboratories financial estimates
Financial estimateRevenue estimate
Valuation estimate
JCB Laboratories leadership team
Management profileNumber of profiles
JCB Laboratories funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
JCB Laboratories M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about JCB Laboratories
What does JCB Laboratories do?
Fagron Sterile Services US is a DEA- and FDA-registered 503B pharmaceutical outsourcing facility that compounds and distributes sterile medication preparations to hospitals, medical centers, and specialty practices. Its portfolio spans pre-filled syringes, IV bags, and unit-of-use presentations across Critical Care, Labor & Delivery, Ophthalmics, Pain Management, and Specialty Presentations, all produced under cGMP-compliant operations inspected against 21 CFR 210 and 211 standards.
Is JCB Laboratories a public or private company?
JCB Laboratories is a private company. It is classified as corporate owned and is currently operating.
When was JCB Laboratories founded?
JCB Laboratories was founded in 2003. It employs 11 to 50 people.
Where is JCB Laboratories based?
JCB Laboratories is headquartered in Wichita, United States, in the North America region.
How does JCB Laboratories make money?
One revenue line is on record: pharmaceutical Compounding Products.
Who are JCB Laboratories's main competitors?
Direct peers on record are Leiters, QuVa Pharma, Empower Pharmacy, AnazaoHealth, Pharmaceutics International (Pii) and US Pharma Lab. Broad incumbents are Patheon (Thermo Fisher Scientific), Hikma Pharmaceuticals, Catalent and Sagent Pharmaceuticals.
Does JCB Laboratories have an API?
No public API is recorded for JCB Laboratories.
What industry is JCB Laboratories in?
JCB Laboratories's product category is Sterile Pharmaceutical Compounding (503B Outsourcing). Its primary akta.pro industry code is HLAIABAH, Generic Finished Dosage Form (FDF) Manufacturing. Its NAICS code is 325412 and its SIC code is 2834.